Endothelial cell activation and hypercoagulability in ocular Behçet's disease

American Journal of Ophthalmology

Volumn 137, Issue 5, 2004, Pages 850-857

  Probst, Kiki ^a   Fijnheer, Rob ^a   Rothova, Aniki ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTEIN C; PROTEIN S; RISTOCETIN; VON WILLEBRAND FACTOR;

ARTICLE; BEHCET DISEASE; BLOOD SAMPLING; CELL ACTIVATION; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EYE DISEASE; FEMALE; HUMAN; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; RETINA MACULA EDEMA; RISK FACTOR; THROMBOSIS; VASCULAR ENDOTHELIUM;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTIGENS; ANTITHROMBIN III; BEHCET SYNDROME; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FACTOR VIII; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; RISTOCETIN; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 2342501872     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.12.010     Document Type: Article

References (38)

1. Sakane T., Takeno M., Suzuki N., Inaba G. Behçet's disease. N Engl J Med. 341:1999;1284-1291
2. Behcet's disease. Lancet 1989;1:761-762
3. Zafirakis P., Foster C.S. Adamantiades-Behçet's disease. Foster C.S., Vitale A.T. Diagnosis and treatment of uveitis. 2002;632-652 WB Saunders, Philadelphia
4. Nussenblatt RB, Whitcup SM, Palestine AG. Behçet's disease. In: Nussenblatt RB, Craven L, Buckwater, editors. Uveitis: fundamentals and clinical practice. 2nd ed. St. Louis: Mosby, 1996:334-353
5. Kural-Seyahi E., Fresko I., Seyahi N., et al. The long-term mortality and morbidity of Behçet's syndrome a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 82:2003;60-76
6. Lee L.A. Behçet's disease. Semin Cutan Med Surg. 20:2001;53-57
7. Wechsler B., Piette J.C., Conard J., Huong Du L.T., Bletry O., Godeau P. Deep venous thrombosis in Behçet's disease 106 localizations in a series of 177 patients. Presse Med. 169:1987;661-664
8. Kiraz S., Ertenli H., Akif Ozturk M., et al. Pathological haemostasis and "prothrombotic state" in Behçet's disease. Thromb Res. 105:2002;125-133
9. Chambers J.C., Haskard O., Kooner J.S. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol. 37:2001;517-520
10. Golden B.D., Goel A., Mitnick H.J. Behçet's-type vasculopathy in a patient without the diagnostic features of Behçet's disease. Arthritis Rheum. 39:1996;1926-1930
11. Ames P.R., Steuer A., Pap A., Denman A.M. Thrombosis in Behcet's disease a retrospective survey from a single UK centre. Rheumatology (Oxford). 40:2001;652-655
12. Bozzoni-Pantaleoni F., Gharbiya M., Pirraglia M.P., Accorinti M., Pivetti-Pezzi P. Indocyanine green angiographic findings in Behçet's disease. Retina. 21:2001;230-236
13. Matsuo T., Sato Y., Shiraga F., Shiragami C., Tsuchida Y. Choroidal abnormalities in Behçet's disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology. 106:1999;295-300
14. Bouchenaki N., Cimino L., Auer C., Tao Tran V., Herbort C.P. Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monatsbl Augenheilkd. 219:2002;243-249
15. Demiroglu H., Barista I., Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology. 104:1997;701-705
16. Behçet's Disease Research Commitee of Japan. Behçet's disease guide to diagnosis of Behçet's disease. Jpn J Ophthalmol. 18:1974;291-294
17. Lisman T., Leebeek F.W., Mosnier L.O., et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 121:2001;131-139
18. Simmelink M.J., Fernandez J.A., Derksen R.H., Griffin J.H., de Groot P.G. Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II. Br J Haematol. 117:2002;676-684
19. Fijnheer R., Horbach D.A., Donders R.C., et al. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost. 76:1996;514-517
20. Lee Y.J., Kang S.W., yang J.I., et al. Coagulation parameters and plasma total homocysteine levels in Behçet's Disease. Thromb Res. 106:2002;19-24
21. Kiraz S., Ertenli I., Ozturk M., et al. Pathological haemostasis and "prothrombotic state" in Behcet's disease. Thromb Res. 105:2002;125-133
22. Demirer S., Sengul N., Yerdel M.A., et al. Haemostasis in patients with Behçet's Disease. Eur J Vasc Endovasc Surg. 19:2000;570-574
23. Mader R., Ziv M., Adawi M., Mader R., Lavi I. Thrombophilic factors and their relationship to thromboembolic and other clinical manifestations in Behçet's disease. J Rheumatol. 26:1999;2404-2408
24. Sengul N., Demirer S., Yerdel M.A., et al. Comparison of coagulation parameters for healthy subjects and Behçet's disease patients with and without vascular involvement. World J Surg. 24:2000;1584-1588
25. Haznedaroglu I.C., Ozcebe O.I., Ozdemir O., Celik I., Dundar S.V., Kirazli S. Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med. 240:1996;181-187
26. O'Donnell J., Laffan M. Elevated plasma factor VIII levels - a novel risk factor for venous thromboembolism. Clin Lab. 47:2001;1-6
27. Kraaijenhagen R.A., in't Anker P.S., Koopman M.M., et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 83:2000;5-9
28. Meijers J.C., Tekelenburg W.L., Bouma B.N., Bertina R.M., Rosendaal F.R. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 342:2000;696-701
29. Kyrle P.A., Minar E., Hirschl M., et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 343:2000;457-462
30. Conard J., Horellou M.H., Wechsler B., et al. Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports. J Mal Vasc. 13:1988;257-261
31. Stathakis N.E., Economopoulos T.C., Papayannis A.G., Thomopoulos D. Platelet function, blood coagulation and fibrinolysis in Behçet's syndrome. Blut. 34:1977;215-222
32. Dupuy E., Tobelem G., Bourgeois P., et al. Parameters of hemostasis in Behçet's disease. Rev Med Interne. 4:1983;317-321
33. Hampton K.K., Chamberlain A., Menon D.K., Davies J.A. Coagulation and fibrinolytic activity in Behçet's disease. Thromb Haemost. 66:1991;292-294
34. Mannucci P.M. Von Willebrand factor. A marker of endothelial damage? Arterioscler Thromb Vasc Biol. 18:1998;1359-1362
35. Er H., Evereklioglu C., Cumurcu T., et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol. 86:2002;653-657
36. Verity D.H., Vaughan R.W., Madanat W., et al. Factor V Leiden mutation is associated with ocular involvement in Behçet's disease. Am J Ophthalmol. 128:1999;352-356
37. Misgav M., Goldberg Y., Zeltser D., Eldor A., Berliner A.S. Fatal pulmonary artery thrombosis in a patient with Behçet's disease, activated protein C resistance and hyperhomocystinemia. Blood Coagul Fibrinolysis. 11:2000;421-423
38. Bertina R.M., Koeleman B.P., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. [comment in Nature 1994;369:14-15] Nature. 369:1994;64-67